{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":null,"indication":null,"name":"HERMES","nct_id":"NCT04595019","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=hermes-nct04595019. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"HERMES","arms":[{"description":"MRI-guided radiotherapy, 36.25 Gray (Gy) in 5 fractions (boost to 40 Gy over tumour/prostate CTV) over 10 days.","label":"5 fraction","type":"ACTIVE_COMPARATOR"},{"description":"MRI-guided radiotherapy, 24 Gy in 2 fractions (boost to 27 Gy over tumour/prostate CTV) over 8 days.","label":"2 fraction","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2028-04-30","type":"ESTIMATED"},"conditions":["Prostate Cancer"],"enrollment":{"count":46,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"SBRT","otherNames":[],"type":"RADIATION"}],"last_update":"2022-06-13","lead_sponsor":"Institute of Cancer Research, United Kingdom","official_title":"The HERMES Trial Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer. A Phase II Randomised Trial of Ultrahypofractionated Stereotactic Body Radiotherapy in Men With Localised Prostate Cancer","overall_status":"RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2028-04-30","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Genitourinary (GU) toxicity","timeFrame":"12 weeks"}],"references":[],"start_date":{"date":"2021-07-29","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer","url":"https://clinicaltrials.gov/study/NCT04595019"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/hermes-nct04595019"}